Genital Warts In Women (cont.)
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
In this Article
- Genital warts (HPV) facts*
- What are human papillomaviruses (HPVs)?
- How common is HPV infection?
- What are the symptoms of genital warts?
- How is HPV infection diagnosed?
- Is there a DNA test for types of HPV infection?
- How are genital warts diagnosed?
- Is there a cure or treatment for external genital warts?
- Precancerous changes (dysplasia) of the cervix
- Can HPV infection be prevented?
- What should a person do if exposed to someone with genital warts?
- Find a local Obstetrician-Gynecologist in your town
Precancerous changes (dysplasia) of the cervix
Women who have evidence of moderate or severe precancerous changes in the uterine cervix require treatment to ensure that these cells do not progress to cancer. In this case, treatment usually involves surgical removal or destruction of the involved tissue. Conization is a procedure that removes the precancerous area of the cervix using a knife, a laser, or by a procedure known as LEEP (loop electrosurgical excision procedure, which uses an electric current passing through a thin wire that acts as a knife). LEEP is also referred to as LLETZ (large loop excision of the transformation zone). Cryotherapy (freezing) or laser therapy may also be used to destroy tissue areas that contain potentially precancerous changes.
Can HPV infection be prevented?
A vaccine is available against common HPV types associated with the development of genital warts and cervical and anogenital carcinomas. This vaccine (Gardasil 9) has received FDA approval for use in females between 9 and 26 years of age and in males aged 9 to 15. It confers immunity against 9 HPV types: 6, 11, 16, 18, 31, 33, 45, 52, and 58. An earlier version of this vaccine (Gardasil) is directed at 4 common HPV types (6, 11, 16, 18). Another vaccine directed at HPV types 16 and 18, known as Cervarix, has been approved for use in females aged 10 to 15.
Learn more about: Cervarix
Abstinence from sexual activity can prevent the spread of HPVs that are transmitted via sexual contact. A person who abstains from sex may still become infected with other HPV types, such as those that cause common skin warts. Some researchers have postulated that HPV infection might be transmitted from the mother to her infant at the time of delivery because some studies have identified genital HPV infection in populations of young children and cloistered nuns. Hand-genital and oral-genital transmission of HPV has also been documented and is another means of transmission.
HPV is usually transmitted by direct genital contact during sexual activity. The virus is not found in or spread by bodily fluids, and HPV is not found in blood or organs harvested for transplantation. Condom use seems to decrease the risk of transmission of HPV during sexual activity, but it does not completely prevent HPV infection. Spermicides and hormonal birth control methods cannot prevent the spread of HPV infection.
Find out what women really need.